As of Sep 23
| +0.0896 / +5.57%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +2,253.49% increase from the last price of 1.70.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.